With more than 70 million customers, 8,500 branches, and over 13,000 ATMs nationwide, the institution handles a diverse capital portfoliofrom branch build-outs and refurbishment to technology hubs supporting its digital transformation
Semaglutide (used in GLP-1 medications like Ozempic and Wegovy) is a peptide drug, and tesamorelin is an FDA-approved synthetic growth hormone-releasing factor analogue
According to Truveta Research presented at ISPOR 2025, side effects were the leading reason patients stopped taking GLP-1 medications, accounting for 28.2% of all discontinuations
It built on an analysis of social media posts on the community network Reddit, in which users reported reduced cravings for alcohol when taking drugs intended to treat Type 2 diabetes and obesity
Global Health
The peptide primes tissue to respond more effectively to growth signals from any source